Cargando…

Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes

INTRODUCTION: Kidney transplantation is the treatment of choice for patients with renal failure. It is crucial to select which patients may benefit from renal transplantation and which are at high risk for post-transplant complications. Sarcopenia is associated with poor outcome in various condition...

Descripción completa

Detalles Bibliográficos
Autores principales: Druckmann, Ido, Yashar, Hila, Schwartz, Doron, Schwartz, Idit F., Goykhman, Yaacov, Kliuk Ben-Bassat, Orit, Baruch, Roni, Tzadok, Roie, Shashar, Moshe, Cohen-Hagai, Keren, Grupper, Ayelet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393828/
https://www.ncbi.nlm.nih.gov/pubmed/35584614
http://dx.doi.org/10.1159/000524774
_version_ 1784771353976504320
author Druckmann, Ido
Yashar, Hila
Schwartz, Doron
Schwartz, Idit F.
Goykhman, Yaacov
Kliuk Ben-Bassat, Orit
Baruch, Roni
Tzadok, Roie
Shashar, Moshe
Cohen-Hagai, Keren
Grupper, Ayelet
author_facet Druckmann, Ido
Yashar, Hila
Schwartz, Doron
Schwartz, Idit F.
Goykhman, Yaacov
Kliuk Ben-Bassat, Orit
Baruch, Roni
Tzadok, Roie
Shashar, Moshe
Cohen-Hagai, Keren
Grupper, Ayelet
author_sort Druckmann, Ido
collection PubMed
description INTRODUCTION: Kidney transplantation is the treatment of choice for patients with renal failure. It is crucial to select which patients may benefit from renal transplantation and which are at high risk for post-transplant complications. Sarcopenia is associated with poor outcome in various conditions, including in chronic kidney disease patients. The gold standard for measuring sarcopenia is computed tomography (CT) imaging to estimate muscle mass and quality since it is objective, reproducible, and reflects the overall health condition. The data regarding those measurements among kidney transplant recipients are limited, therefore we aimed to describe it in patients before kidney transplantation, assess the parameters associated with sarcopenia, and evaluate the clinical significance of those markers on outcomes following transplantation. METHODS: We retrospectively analyzed 183 kidney transplant recipients who had a CT scan 90 days prior to transplant. Sarcopenia was assessed by measuring the cross-sectional area (CSA) and mean muscle density of the psoas muscle at the third and fourth lumbar vertebrae levels and paravertebral muscles at the 12th thoracic vertebra level. RESULTS: There was a strong linear correlation between muscle size measured as CSA of the psoas muscle at the L3 and L4 vertebral body level and the CSA of the paravertebral muscles at the D12 vertebra level, and a moderate correlation to muscle density at those levels. Age was independently associated with risk of sarcopenia, defined as psoas CSA in the lowest tertile, with every year of age increasing the risk by 5%. CSA at the L3 level had a significant independent association with post kidney transplantation mortality, with an adjusted hazard ratio of 0.86 per cm(2). There was a significantly longer hospitalization period postoperation in kidney recipients in the lower tertile of psoas CSA and density. CONCLUSIONS: Sarcopenia as measured by psoas CSA is associated with poor short- and long-term outcomes following kidney transplantation and should be included as part of the assessment of kidney transplantation candidates.
format Online
Article
Text
id pubmed-9393828
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-93938282022-09-23 Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes Druckmann, Ido Yashar, Hila Schwartz, Doron Schwartz, Idit F. Goykhman, Yaacov Kliuk Ben-Bassat, Orit Baruch, Roni Tzadok, Roie Shashar, Moshe Cohen-Hagai, Keren Grupper, Ayelet Am J Nephrol Transplantation: Research Article INTRODUCTION: Kidney transplantation is the treatment of choice for patients with renal failure. It is crucial to select which patients may benefit from renal transplantation and which are at high risk for post-transplant complications. Sarcopenia is associated with poor outcome in various conditions, including in chronic kidney disease patients. The gold standard for measuring sarcopenia is computed tomography (CT) imaging to estimate muscle mass and quality since it is objective, reproducible, and reflects the overall health condition. The data regarding those measurements among kidney transplant recipients are limited, therefore we aimed to describe it in patients before kidney transplantation, assess the parameters associated with sarcopenia, and evaluate the clinical significance of those markers on outcomes following transplantation. METHODS: We retrospectively analyzed 183 kidney transplant recipients who had a CT scan 90 days prior to transplant. Sarcopenia was assessed by measuring the cross-sectional area (CSA) and mean muscle density of the psoas muscle at the third and fourth lumbar vertebrae levels and paravertebral muscles at the 12th thoracic vertebra level. RESULTS: There was a strong linear correlation between muscle size measured as CSA of the psoas muscle at the L3 and L4 vertebral body level and the CSA of the paravertebral muscles at the D12 vertebra level, and a moderate correlation to muscle density at those levels. Age was independently associated with risk of sarcopenia, defined as psoas CSA in the lowest tertile, with every year of age increasing the risk by 5%. CSA at the L3 level had a significant independent association with post kidney transplantation mortality, with an adjusted hazard ratio of 0.86 per cm(2). There was a significantly longer hospitalization period postoperation in kidney recipients in the lower tertile of psoas CSA and density. CONCLUSIONS: Sarcopenia as measured by psoas CSA is associated with poor short- and long-term outcomes following kidney transplantation and should be included as part of the assessment of kidney transplantation candidates. S. Karger AG 2022-07 2022-05-18 /pmc/articles/PMC9393828/ /pubmed/35584614 http://dx.doi.org/10.1159/000524774 Text en Copyright © 2022 by The Author(s). Published by S. Karger AG, Basel https://creativecommons.org/licenses/by-nc/4.0/This article is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC). Usage and distribution for commercial purposes requires written permission. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
spellingShingle Transplantation: Research Article
Druckmann, Ido
Yashar, Hila
Schwartz, Doron
Schwartz, Idit F.
Goykhman, Yaacov
Kliuk Ben-Bassat, Orit
Baruch, Roni
Tzadok, Roie
Shashar, Moshe
Cohen-Hagai, Keren
Grupper, Ayelet
Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes
title Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes
title_full Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes
title_fullStr Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes
title_full_unstemmed Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes
title_short Presence of Sarcopenia before Kidney Transplantation Is Associated with Poor Outcomes
title_sort presence of sarcopenia before kidney transplantation is associated with poor outcomes
topic Transplantation: Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393828/
https://www.ncbi.nlm.nih.gov/pubmed/35584614
http://dx.doi.org/10.1159/000524774
work_keys_str_mv AT druckmannido presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT yasharhila presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT schwartzdoron presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT schwartziditf presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT goykhmanyaacov presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT kliukbenbassatorit presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT baruchroni presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT tzadokroie presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT shasharmoshe presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT cohenhagaikeren presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes
AT grupperayelet presenceofsarcopeniabeforekidneytransplantationisassociatedwithpooroutcomes